CN103884847B - 一种结核分枝杆菌全蛋白质芯片及应用 - Google Patents
一种结核分枝杆菌全蛋白质芯片及应用 Download PDFInfo
- Publication number
- CN103884847B CN103884847B CN201410095163.2A CN201410095163A CN103884847B CN 103884847 B CN103884847 B CN 103884847B CN 201410095163 A CN201410095163 A CN 201410095163A CN 103884847 B CN103884847 B CN 103884847B
- Authority
- CN
- China
- Prior art keywords
- protein
- chip
- interactional
- macrophage
- conjunction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000193830 Bacillus <bacterium> Species 0.000 title claims abstract description 24
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 103
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 96
- 201000008827 tuberculosis Diseases 0.000 claims abstract description 47
- 210000002540 macrophage Anatomy 0.000 claims abstract description 26
- 102000001253 Protein Kinase Human genes 0.000 claims abstract description 23
- 108060006633 protein kinase Proteins 0.000 claims abstract description 23
- 210000002966 serum Anatomy 0.000 claims abstract description 19
- PKFDLKSEZWEFGL-MHARETSRSA-N c-di-GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]3[C@@H](O)[C@H](N4C5=C(C(NC(N)=N5)=O)N=C4)O[C@@H]3COP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 PKFDLKSEZWEFGL-MHARETSRSA-N 0.000 claims abstract description 16
- 239000000758 substrate Substances 0.000 claims abstract description 13
- 238000012216 screening Methods 0.000 claims abstract description 12
- 241000186359 Mycobacterium Species 0.000 claims description 30
- 239000006228 supernatant Substances 0.000 claims description 15
- 108091027963 non-coding RNA Proteins 0.000 claims description 11
- 102000042567 non-coding RNA Human genes 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 238000005336 cracking Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 13
- 108091000080 Phosphotransferase Proteins 0.000 abstract description 10
- 102000020233 phosphotransferase Human genes 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 10
- 238000011160 research Methods 0.000 abstract description 9
- 230000003993 interaction Effects 0.000 abstract description 6
- 150000001875 compounds Chemical class 0.000 abstract description 5
- 239000000090 biomarker Substances 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 3
- 238000013461 design Methods 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 description 32
- 239000000523 sample Substances 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 239000006166 lysate Substances 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 18
- 239000012530 fluid Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000013016 damping Methods 0.000 description 12
- 238000001179 sorption measurement Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 10
- 239000011324 bead Substances 0.000 description 10
- 229910052709 silver Inorganic materials 0.000 description 10
- 239000004332 silver Substances 0.000 description 10
- 239000000975 dye Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000003292 glue Substances 0.000 description 9
- 239000011534 wash buffer Substances 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 8
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 8
- 239000006180 TBST buffer Substances 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 230000001939 inductive effect Effects 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 4
- 229920000297 Rayon Polymers 0.000 description 4
- -1 Rv0526 Proteins 0.000 description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
- 239000004473 Threonine Substances 0.000 description 4
- 108020004417 Untranslated RNA Proteins 0.000 description 4
- 102000039634 Untranslated RNA Human genes 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 101100318415 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Rv1899c gene Proteins 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001215 fluorescent labelling Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000012460 protein solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- YMXHPSHLTSZXKH-RVBZMBCESA-N (2,5-dioxopyrrolidin-1-yl) 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)ON1C(=O)CCC1=O YMXHPSHLTSZXKH-RVBZMBCESA-N 0.000 description 2
- GHKCSRZBNZQHKW-UHFFFAOYSA-N 1-sulfanylethanol Chemical class CC(O)S GHKCSRZBNZQHKW-UHFFFAOYSA-N 0.000 description 2
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 241000187480 Mycobacterium smegmatis Species 0.000 description 2
- 101100385666 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) cut7 gene Proteins 0.000 description 2
- 101100016512 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) hbhA gene Proteins 0.000 description 2
- 101100177645 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) higA3 gene Proteins 0.000 description 2
- 101100128645 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) lpqN gene Proteins 0.000 description 2
- 101100024112 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) mpt51 gene Proteins 0.000 description 2
- 101100360581 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) rmlA gene Proteins 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000000890 drug combination Substances 0.000 description 2
- 238000009509 drug development Methods 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229960003350 isoniazid Drugs 0.000 description 2
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000036457 multidrug resistance Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 229940121649 protein inhibitor Drugs 0.000 description 2
- 239000012268 protein inhibitor Substances 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- 229910001928 zirconium oxide Inorganic materials 0.000 description 2
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 101710138460 Leaf protein Proteins 0.000 description 1
- 101100243377 Mus musculus Pepd gene Proteins 0.000 description 1
- 101100104890 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Rv0498 gene Proteins 0.000 description 1
- 101100459794 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Rv0813c gene Proteins 0.000 description 1
- 101100318149 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Rv1496 gene Proteins 0.000 description 1
- 101100318724 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Rv2578c gene Proteins 0.000 description 1
- 101100051106 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Rv2656c gene Proteins 0.000 description 1
- 101100272887 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) cyp135A1 gene Proteins 0.000 description 1
- 101100443172 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) dhmA2 gene Proteins 0.000 description 1
- 101100065228 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) embR gene Proteins 0.000 description 1
- 101100377720 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) fbpA gene Proteins 0.000 description 1
- 101100512340 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) map gene Proteins 0.000 description 1
- 101100456646 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) menB gene Proteins 0.000 description 1
- 101100131748 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) mtrA gene Proteins 0.000 description 1
- 101100302218 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) nrdF2 gene Proteins 0.000 description 1
- 101100333318 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) nth gene Proteins 0.000 description 1
- 101100194836 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) rimI gene Proteins 0.000 description 1
- 101710089165 Protein white Proteins 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000008364 bulk solution Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940072185 drug for treatment of tuberculosis Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229960005206 pyrazinamide Drugs 0.000 description 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000000814 tuberculostatic agent Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410095163.2A CN103884847B (zh) | 2014-03-14 | 2014-03-14 | 一种结核分枝杆菌全蛋白质芯片及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410095163.2A CN103884847B (zh) | 2014-03-14 | 2014-03-14 | 一种结核分枝杆菌全蛋白质芯片及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103884847A CN103884847A (zh) | 2014-06-25 |
CN103884847B true CN103884847B (zh) | 2015-08-26 |
Family
ID=50953855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410095163.2A Active CN103884847B (zh) | 2014-03-14 | 2014-03-14 | 一种结核分枝杆菌全蛋白质芯片及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103884847B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016024129A1 (en) | 2014-08-15 | 2016-02-18 | Oxford Immunotec Limited | Mycobacterium tuberculosis proteins |
CN105622735B (zh) * | 2014-10-29 | 2019-08-09 | 中国科学院生物物理研究所 | 一组结核分枝杆菌蛋白及其编码基因与应用 |
CN107202894B (zh) * | 2016-03-17 | 2019-02-22 | 广东体必康生物科技有限公司 | Rv1078蛋白在诊断潜伏性/活动性肺结核中的用途 |
CN109406777B (zh) * | 2017-08-18 | 2022-02-18 | 中国科学院生物物理研究所 | 用于特异性检测结核分枝杆菌感染的蛋白Rv2824c |
CN109406776B (zh) * | 2017-08-18 | 2022-02-11 | 中国科学院生物物理研究所 | 用于特异性检测结核分枝杆菌感染的蛋白Rv2818c |
CN108918890B (zh) * | 2018-07-23 | 2021-11-16 | 北京市结核病胸部肿瘤研究所 | 筛选特异性靶向结核分枝杆菌的人的配体蛋白的方法 |
CN108918891B (zh) * | 2018-07-23 | 2021-08-20 | 首都医科大学附属北京胸科医院 | 与人类蛋白nrf1相互作用的结核蛋白及其应用 |
CN110093432B (zh) * | 2019-04-16 | 2022-06-28 | 哈尔滨医科大学 | 一种用于区分结核杆菌和BCG疫苗的sRNA标志物及其用途 |
CN112725484A (zh) * | 2021-01-21 | 2021-04-30 | 哈尔滨医科大学 | 结核分枝杆菌sRNA实时荧光定量PCR标准品及其应用 |
CN114874297A (zh) * | 2022-04-26 | 2022-08-09 | 广东省结核病控制中心 | 一种结核分枝杆菌蛋白组、其筛选方法及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101124335A (zh) * | 2004-07-01 | 2008-02-13 | 加州大学评议会 | 高通量蛋白组学 |
CN101533021A (zh) * | 2009-04-28 | 2009-09-16 | 中国检验检疫科学研究院 | 一种新的检测血清样本中结核抗体的方法和产品 |
CN102718848A (zh) * | 2012-06-01 | 2012-10-10 | 上海交通大学 | 结核分枝杆菌Rv3120的重组蛋白、其制备方法及其在细胞免疫诊断中的应用 |
CN102718871A (zh) * | 2012-06-01 | 2012-10-10 | 上海交通大学 | 结核分枝杆菌特异性标志物Rv1284的重组蛋白、其制备方法及用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003018053A1 (en) * | 2001-08-22 | 2003-03-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Vaccine against mycobacterial-induced diseases |
US10706955B2 (en) * | 2010-03-23 | 2020-07-07 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
WO2013082487A1 (en) * | 2011-11-30 | 2013-06-06 | Children's Hospital Los Angeles | Afsc based therapies |
US9255924B2 (en) * | 2012-10-12 | 2016-02-09 | University Of Notre Dame Du Lac | Exosomes and diagnostic biomarkers |
-
2014
- 2014-03-14 CN CN201410095163.2A patent/CN103884847B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101124335A (zh) * | 2004-07-01 | 2008-02-13 | 加州大学评议会 | 高通量蛋白组学 |
CN101533021A (zh) * | 2009-04-28 | 2009-09-16 | 中国检验检疫科学研究院 | 一种新的检测血清样本中结核抗体的方法和产品 |
CN102718848A (zh) * | 2012-06-01 | 2012-10-10 | 上海交通大学 | 结核分枝杆菌Rv3120的重组蛋白、其制备方法及其在细胞免疫诊断中的应用 |
CN102718871A (zh) * | 2012-06-01 | 2012-10-10 | 上海交通大学 | 结核分枝杆菌特异性标志物Rv1284的重组蛋白、其制备方法及用途 |
Non-Patent Citations (3)
Title |
---|
Mycobacterium tuberculosis Functional Network Analysis by Global Subcellular Protein Profiling;Kwasi G. Mawuenyega et al;《Molecular Biology of the Cell》;20050131;第16卷(第1期);396-404 * |
Mycobacterium Tuberculosis Proteome Microarray for Global Studies of Protein Function and Immunogenicity;Jiaoyu Deng et al;《Cell Report》;20141224;第9卷(第6期);2317-2329 * |
The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds;Simon J. Waddell et al;《Tuberculosis》;20041231;第84卷(第3-4期);131-137 * |
Also Published As
Publication number | Publication date |
---|---|
CN103884847A (zh) | 2014-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103884847B (zh) | 一种结核分枝杆菌全蛋白质芯片及应用 | |
Trubl et al. | Coming-of-age characterization of soil viruses: a user’s guide to virus isolation, detection within metagenomes, and viromics | |
García et al. | Ralstonia solanacearum species complex: a quick diagnostic guide | |
Miranda et al. | RNA viruses as major contributors to Antarctic virioplankton | |
Park et al. | Metagenomic analysis of the viral communities in fermented foods | |
Ulrichs et al. | Modified immunohistological staining allows detection of Ziehl–Neelsen‐negative Mycobacterium tuberculosis organisms and their precise localization in human tissue | |
Miller et al. | Metagenomics for pathogen detection in public health | |
Baddour et al. | Evaluation of three polymerase chain reaction techniques for detection of Brucella DNA in peripheral human blood | |
MEDINA‐SANCHEZ et al. | Detection of a typhus group Rickettsia in Amblyomma ticks in the state of Nuevo Leon, Mexico | |
Poussier et al. | Evaluation of procedures for reliable PCR detection of Ralstonia solanacearum in common natural substrates | |
Singh et al. | Cell extract-containing medium for culture of intracellular fastidious bacteria | |
Buszewski et al. | A new approach to identifying pathogens, with particular regard to viruses, based on capillary electrophoresis and other analytical techniques | |
Abrantes et al. | A review on the methods used for the detection and diagnosis of rabbit hemorrhagic disease virus (RHDV) | |
Kucharski et al. | A comprehensive RNA handling and transcriptomics guide for high-throughput processing of Plasmodium blood-stage samples | |
Boyd et al. | Adaptation of red blood cell lysis represents a fundamental breakthrough that improves the sensitivity of Salmonella detection in blood | |
Nicolas et al. | A subset of viruses thrives following microbial resuscitation during rewetting of a seasonally dry California grassland soil | |
Oteo et al. | Prevalence of spotted fever group Rickettsia species detected in ticks in La Rioja, Spain | |
Rodrigues et al. | Translating the language of giants: translation-related genes as a major contribution of giant viruses to the virosphere | |
Drews et al. | A 24-hour screening protocol for identification of vancomycin-resistant Enterococcus faecium | |
CN105039346A (zh) | 一种与三聚氰胺特异结合的核酸适配体及应用 | |
Saeed et al. | GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it? | |
Chabé et al. | Molecular typing of Pneumocystis jirovecii found in formalin-fixed paraffin-embedded lung tissue sections from sudden infant death victims | |
Argyros et al. | Evaluation of a PCR primer based on the isocitrate dehydrogenase gene for detection of Helicobacter pylori in feces | |
Yao et al. | Development of monoclonal antibody‐coated immunomagnetic beads for separation and detection of norovirus (genogroup II) in faecal extract samples | |
CN105803113A (zh) | 一种同步检测百合隐症病毒和斑驳病毒的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100101 Beijing city Chaoyang District Datun Road No. 15 Patentee after: Institute of Biophysics, Chinese Academy of Sciences Patentee after: SHANGHAI JIAO TONG University Patentee after: Wuhan Institute of Virology, Chinese Academy of Sciences Patentee after: Tibikon Biotechnology (Guangdong) Co.,Ltd. Address before: 100101 Beijing city Chaoyang District Datun Road No. 15 Patentee before: Institute of Biophysics, Chinese Academy of Sciences Patentee before: SHANGHAI JIAO TONG University Patentee before: Wuhan Institute of Virology, Chinese Academy of Sciences Patentee before: TB Healthcare Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |